Stock Comparison
ABBV vs LLY
AbbVie Inc and Eli Lilly and Company side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$439.97B
$1.04T
P/E (TTM)
70.3
39.1
Forward P/E
17.7
32.1
Price/Sales
6.8
13.0
Price/Book
51.1
30.6
EV/EBITDA
25.8
26.0
Dividend Yield
2.03%
0.53%
Profitability
Net Margin
9.82%
33.53%
Operating Margin
29.77%
43.92%
Return on Equity
62.30%
102.30%
Return on Assets
10.50%
20.40%
Growth (YoY)
Revenue Growth
10.20%
47.70%
Earnings Growth
290.40%
26.20%
Price & Risk
Beta
0.3
0.5
52-Week High
$263.65
$1,235.65
52-Week Low
$197.38
$679.67
Analyst Target
$274.36
$1,297.31
Compare ABBV and LLY your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.